Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

EVE TRIAL , ALMA SYSTAM

NCT: NCT06646653 · RECRUITING

NCT IDNCT06646653
StatusRECRUITING
Start Date2026-01-11
Completion2027-04

Brief Summary

abnormal bleeding after childbirth. This condition is called abnormal bleeding and becomes a condition known as postpartum hemorrhage (PPH) when worsens. Abnormal bleeding is defined as the loss of more than 500 milliliters (about two cups) of blood after a vaginal birth, or more than 1,000 milliliters (about four cups) after a cesarean section. It is a serious and potentially life-threatening complication that requires immediate medical treatment. What you need to know: * Signing this form does not mean you will have an emergency postpartum bleeding. * We will only include you in the study IF abnormal bleeding happens after your birth. * If abnormal bleeding does happen, your doctors will first try the usual treatments that work in accordance with the hospital's PPH protocol. * The study device (called Alma system) would only be used if the usual treatments do not stop the bleeding. Treatment Schedule - Recruitment \& Consenting * Screening and enrolment. * Treatment of PPH with Alma system. * Alma Survey * Follow up examination post treatment procedure (after removal of Alma system and before subject discharge from the hospital). * 6-week postpartum follow-up examination.

Frequently Asked Questions

What is EVE TRIAL , ALMA SYSTAM?

EVE TRIAL , ALMA SYSTAM is a clinical trial registered under NCT06646653. Current status: RECRUITING.

What is the status of NCT06646653?

The current status of NCT06646653 (EVE TRIAL , ALMA SYSTAM) is: RECRUITING.

When did EVE TRIAL , ALMA SYSTAM start?

EVE TRIAL , ALMA SYSTAM started on 2026-01-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.